Proteocyte Diagnostics' Straticyte Receives Further NRC-IRAP Support

Proteocyte Diagnostics Inc. announced new support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) for their novel prognostic oral cancer laboratory service.

View the full press release on the Proteocyte website here

Previous
Previous

CAAP Company: AprilAge's Face Aging Software, APRIL® Now Being Used in 34 countries

Next
Next

CAAP Company: KA Imaging Launches New Website